Chouaki, T.
Publications
P305
Medical Mycology, 2025, 63, 12.
Multi-fungicide resistance in both clinical and environmental isolates of the human fungal pathogen Aspergillus fumigatus.
P286
J. Mycol. Med. 2024, 34, 101490.
Current knowledge and practice of Candida auris screening in France: A nationwide survey from the French Society of Medical Mycology (SFMM).
P255
mBio. 2022, e0092022.
French mycoses study group. Active surveillance program to increase awareness on invasive fungal diseases: the French RESSIF network (2012 to 2018).
P226
J. Mycol. Med. 2020, 30, 100970.
Antifungal susceptibility testing practices in mycology laboratories in France, 2018.
doi: 10.1016/j.mycmed.2020.100970
P172
Mycoses 2018, 61, 30-34.
PCR-based detection of A. fumigatus and absence of azole resistance due to TR34/L98H in a french multicenter cohort of 137 patients with fungal rhinosinusitis.
doi: 10.1111/myc.12702
P163
Home environment as a source of life-threatening azole-resistant Aspergillus fumigatus in immunocompromised patients.
doi: 10.1093/cid/ciw664
P147
Antimicrob. Agents Chemother. 2016, 60, 5088-5091.
Multicenter Comparison of the Etest and EUCAST Methods for Antifungal Susceptibility Testing of Candida Isolates to Micafungin.
doi: 10.1128/AAC.00630-16
Autres publications scientifiques
PS40
Emerg. Infect. Dis. 2025, 31, 896-905.
Features of Invasive Aspergillosis Caused by Aspergillus flavus, France, 2012-2018.